Live tape
Top 8, mentions 7d2,137GOOGL453 mentions▲ +0.06NVDA345 mentions▲ +0.07META271 mentions▲ +0.05QQQ266 mentions▲ +0.09SPY256 mentions▲ +0.04AAPL193 mentions▲ +0.04MSFT178 mentions▲ +0.06TSLA175 mentions▲ +0.06

Equity · Healthcare

NTHI

NeOnc Technologies Holdings, Inc. · NasdaqGM

$3.46 −0.57% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 19 sessions
$6 $3 22 Jun 17 Jul

The line runs $5.17 on 22 June through $3.46 on 17 July, on a scale from $3 to $6. Days the market did not trade hold the previous close, flat.

The chart above plots the price of NTHI over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 19 sessions over that window: $5.17 on 22 June 2026 through $3.46 on 17 July 2026.

Market cap $89.7M
52-week range $3.46 – $13
Avg volume 12.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 20, 2026

NTHI insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Sep 2026
Open-market buys 12
Open-market sells 1
Net bought $793K
Non-trade filings 0
Date Insider Type Shares Value
15 Sep 2026 Heshmatpour Amir F CEO, President Buy 35,000 $115K
15 Sep 2026 GARNETT KEITHLY CFO Sell 5,000 $17K
14 Sep 2026 CHEN THOMAS C CEO Buy 5,242 $20K
14 Sep 2026 GARNETT KEITHLY CFO Buy 257 $1K
14 Sep 2026 Heshmatpour Amir F CEO, President Buy 15,000 $59K
11 Sep 2026 Heshmatpour Amir F CEO, President Buy 37,000 $136K
11 Sep 2026 CHEN THOMAS C CEO Buy 5,556 $20K
18 Aug 2026 Heshmatpour Amir F CEO, President Buy 9,000 $50K
18 Aug 2026 CHEN THOMAS C CEO Buy 12,757 $70K
17 Aug 2026 Heshmatpour Amir F CEO, President Buy 3,000 $13K
17 Aug 2026 CHEN THOMAS C CEO Buy 4,944 $20K
14 Aug 2026 Heshmatpour Amir F CEO, President Buy 12,000 $45K

Showing the 12 most recent of 13 open-market trades in this window. The figures above count all of them.

NTHI reported financials

SEC EDGAR XBRL

NTHI reported revenue of $40K for the fiscal year ended 31 Dec 2025. Net income over the same period was −$62.1M.

Figure Reported Period
Revenue $40K 31 Dec 2025 fiscal year
Net income −$62.1M 31 Dec 2025 fiscal year
Diluted EPS −$3.20 31 Dec 2025 fiscal year
Total assets $5.2M 30 Jun 2026 at period end
Total equity −$18.5M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

NTHI earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.58
31 Mar 2026 Q1 2026 $-0.38
31 Dec 2025 FY 2025 $-3.20 $0M
30 Sep 2025 Q3 2025 $-0.45 $0M
30 Jun 2025 Q2 2025 $-0.30 $0M
31 Mar 2025 Q1 2025 $-1.78 $0M
31 Dec 2024 FY 2025 $-0.69 $0M
30 Sep 2024 Q3 2025 $-0.12 $0M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

NTHI institutional holders

SEC Form 13F

1 of the 45 institutional funds we track reported a NTHI position for the quarter ended 30 Jun 2026 — a combined $99K; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Marshall Wace Added +73.2% shares 21,784 $99K

Source: SEC EDGAR 13F filings

NTHI fails-to-deliver

SEC CNS data

On 31 Aug 2026, 1,092 shares of NTHI failed to deliver (about $5K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 1,092 $5K 0.004%
18 Aug 2026 48 $236 <0.001%
17 Aug 2026 122 $515 <0.001%
14 Aug 2026 500 $2K 0.002%
13 Aug 2026 27,936 $97K 0.108%

Source: SEC fails-to-deliver (CNS) data